Podcasts about Ambulatory

As health systems anticipate greater downward pressures on margins in the months and years to come, they're homing their growth strategies accordingly. As we've been saying in our research the past couple of years, “sustainability” is now the name of the game. Here's the conundrum: our research also shows that 90% of systems are betting on the same growth plays as their competition. And more and more, those bets converge on a common goal: win more commercial volumes. In this episode, host Abby Burns sits down with Advisory Board experts Shay Pratt and Emily Heuser to unpack the three main avenues health systems are exploring to win commercial volumes: ambulatory care, service lines, and direct-to-employer contracting. For each, they explore a “hard truth” and corresponding mindset shift leaders must face as they weigh what it will take to generate margin-accretive growth. We're here to help: Ambulatory research | Ambulatory care Market trends research | Market trends and growth strategy Service line research | Service lines and specialty care Episode | 290: How data savvy strategic planners will define the next era of health system growth Playlist | Provider Strategy and Financial Outlook playlist Tool | Check out Advisory Board's Market Scenario Planner and other Advisory Board analytics and data tools to inform your strategy for growth, cost control and more. Learn more about Advisory Board's 2026 summit series. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, Laura Dyrda, Vice President, Editor-in-Chief, Becker's Healthcare, discusses how health systems are navigating AI adoption, strengthening cybersecurity defenses, managing emerging technology costs, and responding to major shifts in ambulatory care strategy and healthcare consolidation.

In this episode, David Kelly, Chief of Ambulatory Operations and Vice President of Revenue Cycle at Mary Rutan Health, joins the podcast to discuss financial assistance programs that help patients access the care they need. He also shares insights on the importance of care coordination and strategic partnerships in improving patient outcomes, enhancing the care experience, and supporting long-term organizational success.

In this episode, David Kelly, Chief of Ambulatory Operations and Vice President of Revenue Cycle at Mary Rutan Health, joins the podcast to discuss financial assistance programs that help patients access the care they need. He also shares insights on the importance of care coordination and strategic partnerships in improving patient outcomes, enhancing the care experience, and supporting long-term organizational success.

Does multi- level surgery weaken muscles in ambulatory youth with CP?

Ambulatory Surgical Centers (ASCs) have been around in concept for the past fifty years, but their recent explosion has caught the attention of healthcare systems and, frankly, patients. Why? Today's guest, Adnan Qureshi, is a Managing Director with the Mergers and Acquisitions practice at Kaufman Hall. He provides strategic advisory services for healthcare providers and investors around the merger or acquisition of ASCs. The benefit he's seen in partnership with his clients perhaps explains the answer to this question. The “DNA”, as Adnan puts it, of the ASC is rooted in independent physicians who, as an extension of their practice, saw the benefit of doing lower acuity surgeries in an outpatient setting. As pain management and technology improved over time, the use case also evolved to the point where there are now few specialty areas where uncomplicated surgeries cannot be performed in an ASC. Without the overhead and operating costs of a hospital, ASCs allow for far more transparent pricing, lower costs, greater efficiency, and often better outcomes, all driving towards higher patient satisfaction. And that's a win we should all be paying attention to. Adnan Qureshi has over fifteen years of healthcare transaction experience. Prior to joining Kaufman Hall, he was a Director of Development at SCA Health, a subsidiary of Optum/UnitedHealth Group. In that role, Mr. Qureshi led market entry strategy across several geographies, and sourced, structured, and executed ambulatory surgery center acquisitions.

Access to care in an ambulatory setting continues to challenge health systems as patient expectations grow, pushing organizations to rethink how patients connect with care. Our host Michelle Lewis joins Tyler Bauer, Senior Vice President of System Ambulatory Operations at University of Chicago Medicine to explore how their team is transforming access through more connected and intuitive processes.  Guest: Tyler Bauer, MA, MBA, LCPC Senior Vice President, System Ambulatory Operations UChicago Medicine   Host: Michelle Lewis Senior Director Programs, Performance Improvement Programs Vizient    Show Notes:  [00:45] Areas of improvement in ambulatory access  [02:16] Biggest pain points for patients: connectedness, personalization, and navigation  [03:51] Creating an omnichannel experience  [04:43] AI tools being brought in to help with access strategy  [06:18] Using ambient listening and other AI tools to make a difference for patients and staff  [08:26] Organizational buy-in and compliance with AI application strategy  [10:31] Advice to other healthcare organizations    Links | Resources: Contacting Knowledge on the Go: picollaboratives@vizientinc.com    Subscribe Today! Apple Podcasts Spotify YouTube Android RSS Feed  

Cardiology is shifting from inpatient to outpatient care. In this MedAxiom HeartTalk, host Melanie Lawson, MS, talks with Amy Brownell, MSN, FNP-C, FACC, cardiovascular service line director at Ascension Illinois Market about strategies for expanding ASCs and office-based labs while maintaining clinical quality. They also discuss operational and financial considerations that help health systems thrive in this changing landscape.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction.

In healthcare, access to care ultimately comes down to one fundamental challenge: balancing supply and demand. In this episode of the Patient Access Collaborative podcast, Executive Director Elizabeth Woodcock speaks with Chris Profeta, Senior Director of Research and Analytics, about the emergence of ambulatory capacity management as a critical discipline within patient access. Together, they reflect on the rapid growth of the field - from a time when only a handful of professionals focused on capacity management to today's sold-out roadshows and growing national attention. The conversation explores why traditional market dynamics don't function in healthcare, how technological advances like automated waitlists are reshaping access to care, and why understanding true patient demand remains the next frontier for health systems.  

Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.Click here to read the full article, Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a randomised sham-controlled trialhttps://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00005-6/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Historically, peer review was limited to the review of practitioners' clinical care for hospital patients.  However, with health care entities providing more clinical services on an outpatient basis and the increase in employed physicians by hospital affiliated entities, there has been significant interest in developing outpatient peer review processes.  But, before moving forward with such a project, there are a number considerations that groups have to evaluate.  For example, the structure that is used for hospital peer review processes usually isn't required for outpatient peer review.  A more streamlined process is often appropriate and permits groups to make the best of their limited resources.  Also, some state peer review statutes may not extend protections to outpatient peer review.  Therefore, other options for protection need to be considered.  During The Brave New World of Ambulatory Peer Review podcast, Ian Donaldson and Charlie Chulack will touch on these topics and more to assist you in designing your outpatient peer review process.

In this episode, Nancy Beran, MD, Vice President and Chief Quality Officer of ambulatory care at Northwell Health, shares how her team screened more than 700,000 patients for depression, redesigned ambulatory quality oversight across 1,000 sites, and is leading integration and Epic implementation to drive safer, more standardized care.

In this episode, Nancy Beran, MD, Vice President and Chief Quality Officer of ambulatory care at Northwell Health, shares how her team screened more than 700,000 patients for depression, redesigned ambulatory quality oversight across 1,000 sites, and is leading integration and Epic implementation to drive safer, more standardized care.

Dr. George Tewfik, guest editor of the March ASA Monitor, and Dr. Emily Methangkool, contributor, discuss ambulatory anesthesia with Dr. Zach Deutch. Learn how ambulatory surgery centers (ASCs) are transforming care, how practicing in an ASC differs from the inpatient setting, what is on the horizon, and more. Recorded January 2026. 

Ambulatory leaders may believe care access problems are solved because their utilization metrics are high. However, these numbers may be hiding demand mismatches at the patient, provider, and clinic level. Discover how examining patient mix, no-shows, and late cancellations can help boost access to care and stop revenue leakage. 

Orthopedic surgery is in the middle of a quiet but powerful shift. Procedures that once required hospital admission are increasingly being performed in Ambulatory Surgery Centers (ASCs), and this change is transforming patient experience, physician autonomy, and the business of orthopedic care. In our latest podcast episode, Dr. Spector joins us to discuss why ASCs are becoming a dominant force in modern orthopedics. In this episode, we break down: Why more orthopedic procedures are moving out of hospitals. How ASCs are transforming patient experience, efficiency, and recovery. OrthoCarolina's bold strategy to double down on ASCs and physician-led care. The real financial differences between ASCs and hospitals for patients, insurers, and providers. Certificate of need, and the role it plays in ASCs. How ASCs and hospital partnerships work. A board-certified fellowship-trained Orthopedic spine surgeon, Dr. Spector has enjoyed a 17-year tenure with OrthoCarolina, holding multiple leadership positions, including Chief Executive Officer, Chief Quality Officer, member of the Executive Committee, chairman of the Quality/Value Committee, and co-fellowship director at the OrthoCarolina Spine Center. In 2020, Dr. Spector earned his MBA from Duke University Fuqua School of Business and was previously selected to participate in the American Orthopedic Association Leadership Program, conducted in collaboration with the University of Chicago Booth School of Business. Dr. Spector currently serves as a Board Member of the Lumbar Spine Research Society and previously held the position of President of the North Carolina Spine Society. Dr. Spector began serving as CEO of OrthoCarolina in 2024. Dr. Spector has continued to practice orthopedic surgery while active as the OrthoCarolina CEO.  

If you've ever wondered why ambulatory EHRs feel stuck in time, you're not alone. A lot of clinicians and IT leaders have been waiting for signs of real movement, and this conversation surfaces why the shift may finally be underway.In this interview, Troy Wasilefsky, Chief Revenue Officer at Greenway Health, talks about the stagnant EHR market, the practical roles AI can play inside physician practices, and why owning both the clinical record and the automation layer matters. He shares direct feedback from customers, where AI helps most, and how the architecture of EHR systems is finally catching up to long-promised functionality.Where do you see AI making the biggest near-term difference in ambulatory care? Drop your thoughts in the comments.

In this episode, Molly Moran, Associate Vice President of Ambulatory Nursing at Rush University Medical Center, joins the podcast to discuss the destabilization of insurance coverage and affordability, the growing role of nurse-led telephone triage, and how health systems can better meet patient needs across the ambulatory setting. She also shares insights on intentional leadership and what it takes to support nurses while delivering accessible, patient-centered care.

In this episode, Molly Moran, Associate Vice President of Ambulatory Nursing at Rush University Medical Center, joins the podcast to discuss the destabilization of insurance coverage and affordability, the growing role of nurse-led telephone triage, and how health systems can better meet patient needs across the ambulatory setting. She also shares insights on intentional leadership and what it takes to support nurses while delivering accessible, patient-centered care.

CME credits: 0.25 Valid until: 30-01-2027 Claim your CME credit at https://reachmd.com/programs/cme/missing-the-window-in-ambulatory-patients-with-hfref-on-gdmt-strategies-for-cv-risk-reduction/48813/ For ambulatory patients with heart failure with reduced ejection fraction (HFrEF) who have not experienced a recent worsening event, cardiologists continue to face a major clinical challenge: persistent and under-recognized cardiovascular (CV) risk. Despite adherence to quadruple guideline-directed medical therapy (GDMT) and device support, these “stable,” guideline-treated patients carry residual risk for CV death. Recent evidence shows that the addition of soluble guanylate cyclase (sGC) stimulators provides significant reductions in CV death and all-cause mortality, particularly in individuals with moderately elevated NT-proBNP (≤6,000 pg/mL). However, cardiologists often underestimate risk in these ambulatory patients and may hesitate to add therapies when GDMT appears to be working well. Our experts break down a case to illustrate how and when to employ recent data regarding the use of additional sGC in appropriate patients with HFrEF.=

In this episode, Anna Liza Rodriguez, Vice President, Nursing and Patient Care Services and Chief Nursing Officer, Fox Chase Cancer Center discusses the organization's ambulatory care excellence model, highlighting role clarity, staffing optimization, and improved care coordination. She also shares priorities for 2026, including nursing innovation, workforce engagement, and more.

Ambulatory and acute care billing share many of the same building blocks, but the way data, workflows, and reimbursement are structured creates very different operational realities. In this episode, we explore how those differences shape not only revenue cycle strategy, but also how automation and AI should be applied effectively with these considerations across care settings.

In this episode, Dr. Sunil Verma, Chief Medical Officer for Ambulatory at UCI Health, discusses rapid health system growth, an ambulatory first strategy, and the role of physician leadership in expanding access, aligning clinicians, and sustaining high quality care.

In this episode, Justin L. Vesser, PharmD, MS, Director of Ambulatory Pharmacy at UVA Health, shares how his team expanded clinical pharmacy services, improved medication access, and grew retail operations to better serve patients across Virginia. He also discusses navigating reimbursement pressures, regulatory headwinds, and leading through change by anchoring pharmacy teams in a clear mission.

Chegou o episódio escolhido por vocês! Marcela Belleza e Joanne Alves convidam Carol Millon para conversar sobe 6 clinicagens de inibidores de SGLT2, as gliflozinas:Indicações além do DMRisco de CAD euglicêmicaQuando não usar?⁠Cuidados com doença aguda (sick day) e hipovolemia⁠Cuidados pré-operatórioRisco de fratura e amputaçãoReferências:1. Bailey CJ, et al. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. Published 2013 Feb 20. doi:10.1186/1741-7015-11-432. Bersoff-Matcha SJ, et al. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019;170(11):764-769. doi:10.7326/M19-00853. Chang HY, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-1198. doi:10.1001/jamainternmed.2018.3034 4. Clar C, et al. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012 Oct 18;2(5):e001007. doi: 10.1136/bmjopen-2012-001007. PMID: 23087012; PMCID: PMC3488745.5. Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583. 6. Fralick M, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. Published 2020 Aug 25. doi:10.1136/bmj.m28127. Li D, et al. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355. doi:10.1111/dom.128258. Neal B, et al. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J. 2013;166(2):217-223.e11. doi:10.1016/j.ahj.2013.05.0079. Nyirjesy P, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173-1178. doi:10.1185/03007995.2012.69705310. Perkovic V, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-2306. doi:10.1056/NEJMoa181174411. Rosenwasser RF, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.12. Sridharan K, Sivaramakrishnan G. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opin Drug Saf. 2025;24(7):797-804. doi:10.1080/14740338.2024.237775513. Ueda P,  et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018;363:k4365. Published 2018 Nov 14. doi:10.1136/bmj.k436514. Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Jan;101(1):157-66. doi: 10.1210/jc.2015-3167. Epub 2015 Nov 18. PMID: 26580237; PMCID: PMC4701850.15. Zhuo M, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021;4(10):e2130762. Published 2021 Oct 1. doi:10.1001/jamanetworkopen.2021.3076216. Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho,  Antonio Carlos Aguiar Brandão, Ruy Lyra e Marcello Bertoluci. Rastreamento e Controle da Hiperglicemia no Perioperatório – Posicionamento Conjunto da Sociedade Brasileira de Diabetes (SBD), Sociedade Brasileira de Anestesiologia (SBA) e Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO). Diretriz Oficial da Sociedade Brasileira de Diabetes (2025). DOI: 10.29327/5660187.2025-10 , ISBN: 978-65-5941-367-6.17. Singh LG, Ntelis S, Siddiqui T, Seliger SL, Sorkin JD, Spanakis EK. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2024;47(6):933-940. doi:10.2337/dc23-112918. Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Endocr Pract. 2022;28(9):884-888. doi:10.1016/j.eprac.2022.06.00619. Umapathysivam MM, Morgan B, Inglis JM, et al. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw Open. 2024;7(3):e242744. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.274420. Fleming N, Hamblin PS, Story D, Ekinci EI. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. J Clin Endocrinol Metab. 2020;105(8):dgaa200. doi:10.1210/clinem/dgaa20021. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi:10.1016/S2213-8587(19)30256-622. Braunwald E. Gliflozins in the Management of Cardiovascular Disease. N Engl J Med. 2022;386(21):2024-2034. doi:10.1056/NEJMra211501123. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa150472024. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377(7):644-657. doi:10.1056/NEJMoa161192525. Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa181238926. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa191130327. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJMoa202219028. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa210703829. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa202481630. The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in...

This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Jeffrey Flynn, President of the New York State Association of Ambulatory Surgery Centers. He shares insights on market growth, the rising role of AI and robotics, and how partnerships with health systems are shaping patient care and operational efficiency in the ASC space.

This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Jeffrey Flynn, President of the New York State Association of Ambulatory Surgery Centers. He shares insights on market growth, the rising role of AI and robotics, and how partnerships with health systems are shaping patient care and operational efficiency in the ASC space.

This episode recorded live at Becker's 31st Annual The Business and Operations of ASCs features Jeffrey Flynn, President of the New York State Association of Ambulatory Surgery Centers. He shares insights on market growth, the rising role of AI and robotics, and how partnerships with health systems are shaping patient care and operational efficiency in the ASC space.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com The future of healthcare lies in intelligent automation that gives providers back their time. In this episode, David Cohen, Chief Product and Technology Officer at Greenway Health, explains how AI and automation are reshaping the ambulatory healthcare experience from “encounter to cash.” He outlines the company's agentic-first architecture, which embeds intelligent automation into the core of the product to streamline clinical, operational, and financial workflows. David showcases real-world applications, including ambient documentation, automated billing, and chart review powered by AWS HealthLake, that reduce administrative burden and improve care coordination. He also highlights Greenway's customer-driven “working backwards” approach and their focus on delivering measurable impact within months, not years. Tune in and learn how intelligent, end-to-end automation is redefining efficiency, accessibility, and care quality in ambulatory healthcare! Resources Connect with and follow David Cohen on LinkedIn. Follow Greenway Health on LinkedIn and visit their website!

About David Cohen:David Cohen, FACHE, serves as the Chief Product and Technology Officer at Greenway Health, leading the company's technology and product strategy to drive digital healthcare innovation. Since joining in 2019, he has played a key role in modernizing Greenway's solutions and driving better outcomes for providers and patients. He also serves on the Board of the CommonWell Health Alliance, promoting interoperability across the healthcare ecosystem.Previously, David spent over 13 years at Cerner Corporation in leadership roles spanning Cerner Intelligence, Clinical Solutions, and Innovation. He began his career in technology and consulting with Pfizer and ThoughtWorks. David holds an MBA from The University of Chicago Booth School of Business and a BA in Integrated Science and Mathematics from Northwestern University.Things You'll Learn:Intelligent automation is central to transforming ambulatory healthcare, enabling providers to reduce administrative tasks and allocate more time to patient care.Greenway's “agentic-first architecture” treats AI not as a tool but as the core product, enabling end-to-end workflow automation across the encounter-to-cash spectrum.By working closely with customers and using a “working backwards” approach, Greenway designs solutions that directly address real-world practice challenges.Automation in documentation, chart review, and revenue cycle management enhances efficiency and improves care coordination through platforms like AWS HealthLake.David emphasizes “time compression,” focusing on delivering innovation within months rather than years to meet the urgent needs of healthcare providers.Resources:Connect with and follow David Cohen on LinkedIn.Follow Greenway Health on LinkedIn and visit their website. 

In this episode, Kathleen Hickman, RN, BSN, MS, CASC, Administrator and Clinical Director of Dutchess Ambulatory Surgical Center, shares insights on ASC growth through higher acuity cases, the impact of new CMS codes, and how innovation and culture are shaping the future of surgical care.

In this episode, Kathleen Hickman, RN, BSN, MS, CASC, Administrator and Clinical Director of Dutchess Ambulatory Surgical Center, shares insights on ASC growth through higher acuity cases, the impact of new CMS codes, and how innovation and culture are shaping the future of surgical care.

In this episode, Kathleen Hickman, RN, BSN, MS, CASC, Administrator and Clinical Director of Dutchess Ambulatory Surgical Center, shares insights on ASC growth through higher acuity cases, the impact of new CMS codes, and how innovation and culture are shaping the future of surgical care.

In this episode, Scott Becker speaks with Alan Condon, Editor-in-Chief at Becker's Healthcare, about key healthcare developments including updates on the ACA subsidy extension, the federal spending package, and Ascension's $3.9 billion acquisition of AMSURG that could reshape the outpatient surgery landscape.

On this episode, Prasana Ruxmohan, MHA, Ambulatory Operations Transformation Specialist at UCI Health, joins the podcast to discuss educating staff on new technology, the best opportunities for growth in the future including virtual access and proactive outreach, and responsibly integrating technology.

The shift to outpatient surgery is transforming how care is delivered. In this episode, Dr. Adam Thaler, Medical Director at Summit Health, discusses leading a urology-focused ambulatory surgery center and the rapid growth of outpatient procedures. He explains why airway management is the cornerstone of patient safety in ASCs and why he relies on video laryngoscopy, particularly the McGrath MAC, for every case. Dr. Thaler highlights the clinical, financial, and operational benefits of this technology, including reduced complications, improved efficiency, and enhanced patient experience. He also shares advice for ASC leaders on embracing innovation, doing their own research, and treating every patient with the same high standard of care. Tune in to hear how Dr. Thaler is shaping the future of outpatient surgery! Resources: Connect with and follow Dr. Adam Thaler on LinkedIn. Follow Summit Health on LinkedIn and explore their website! Check out Dr. Adam Thaler's Medtronic blog on How the intubation tools you choose can affect your facility's costs and more! References: Leifer S, Choi SW, AsanatiK, YentisSM. Upper limb disorders in anaesthetists-a survey of Association of Anaesthetistsmembers. Anaesthesia. 2019;74(3):285-291. doi:10.1111/anae.14446 Kriege M, Noppens R, TurkstraT, et al. A multicentrer randomized controlled trial of the McGrath MAC video laryngoscope versus conventional laryngoscopy. Anaesthesia. 2023;78(6):722-729. Zhang J, Jiang W, Urdaneta F. Economic analysis of the use of video laryngoscopy versus direct laryngoscopy in the surgical setting. Journal of Comparative Effectiveness Research. 2021;10(10):831-844. doi:https://doi.org/10.2217/cer-2021-0068 Nørskov AK, Rosenstock CV, Wetterslev J, Astrup G, Afshari A, Lundstrøm LH. Diagnostic accuracy of anaesthesiologists' prediction of difficult airway management in daily clinical practice: a cohort study of 188,064 patients registered in the Danish Anaesthesia Database. Anaesthesia. 2015;70(3):272-281. Kleine-Brueggeney M, Greif R, Schoettker P, Savoldelli GL, Nabecker S, Theiler LG. Evaluation of six video laryngoscopes in 720 patients with a simulated difficult airway: a multicentre randomized controlled trial. Br J Anaesth. 2016;116(5):670-9. Thaler A, Mohamod D, Toron A, Torjman MC. Cost comparison of 2 video laryngoscopes in a large academic center. Journal of Clinical Outcomes Management. 2021 July;28(4):174-179. Moucharite MA, et al. Factors and economic outcomes associated with documented difficult intubation in the United States. Clinicoecon Outcomes Res. 2021;13:227–239. Gaszyński T. Comparison of the glottic view during video-intubation in super obese patients: a series of cases. Ther Clin Risk Manag. 2016;12:1677–1682. Alvis BD, Hester D, Watson D, Higgins M, St Jacques P. Randomized controlled trial comparing the McGRATH™ MAC video laryngoscope with the King Vision video laryngoscope in adult patients. Minerva Anestesiol. 2016;82(1):30–35.

In this Special Episode of the ASC Podcast with John Goehle recorded live from the New York State Association of Ambulatory Surgery Centers 2025 Annual Conference in Albany, New York we interview some of the speakers and discuss recent activities for the association and the benefits of membership in the Association. This episode is sponsored by Surgical Information Systems, RFX Solutions, Medserve and  Ambulatory Healthcare Strategies.   Notes and Resources from this Episode: Link to the New York State Association Website: https://www.nysaasc.org/ INFORMATION ABOUT THE ASC PODCAST WITH JOHN GOEHLE ASC Central, a sister site to http://ascpodcast.com provides a link to all of our bootcamps, educational programs and membership programs! http://conferences.asc-central.com Join one of our Membership Programs! Our Patron Program: Patron Members of the ASC Podcast with John Goehle have access to ASC Central - an exclusive membership website that provides a one-stop  ASC Regulatory and Accreditation Compliance, Operations and Financial Management resource for busy Administrators, nurse managers and business office managers.  More information and Become Member The ASC-Central Premium Access Program A Premium Resource for Ambulatory Surgery Centers including access to bootcamps, education programs and private sessions More Information and Become a Premium Access Program Members Today! Important Resources for ASCs: Conditions for Coverage: https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&rgn=div5&view=text&node=42:3.0.1.1.3&idno=42#se42.3.416_150 Infection Control Survey Tool (Used by Surveyors for Infection Control) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107_exhibit_351.pdf Updated Guidance for Ambulatory Surgical Centers - Appendix L of the State Operations Manual (SOM) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_l_ambulatory.pdf https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/updated-guidance-ambulatory-surgical-centers-appendix-l-state-operations-manual-som Policy & Memos to States and Regions CMS Quality Safety & Oversight memoranda, guidance, clarifications and instructions to State Survey Agencies and CMS Regional Offices. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions Other Resources from the ASC Podcast with John Goehle: Visit the ASC Podcast with John Goehle Website Books by John Goehle Get a copy of John's most popular book - The Survey Guide - A Guide to the CMS Conditions for Coverage & Interpretive Guidelines for Ambulatory Surgery Centers 

This week, hosts Heather and Matthew are joined by Mark Wainner, President of the Ambulatory Surgery Center Association (ASCA), to explore how ambulatory surgery centers (ASCs) are transforming the health care landscape. With over 6,400 Medicare-certified ASCs nationwide, these facilities are delivering high-quality, cost-effective care while saving Medicare billions. Mark shares insights on the latest regulatory changes, quality reporting, and overall industry growth. We also dive into the challenges ahead, including anesthesia shortages and physician employment trends. Tune in for a look at the future of outpatient surgical care!

Discusses the Centers for Medicare & Medicaid Services' proposed rule for the 2026 hospital outpatient prospective payment system and ambulatory surgical centers. Our guest today is Eric Tower, a partner at the law firm Blank Rome. Eric serves as a trusted advisor to healthcare clients on a wide range of corporate transactional and operational matters. He is well-versed in handling mergers and acquisitions, joint ventures, fraud and abuse compliance, physician practice acquisitions, financing, litigation, and corporate governance matters. Additional resources: CMS fact sheet: https://www.cms.gov/newsroom/fact-sheets/calendar-year-2026-hospital-outpatient-prospective-payment-system-opps-and-ambulatory-surgical Impact of Recent CMS Rule on Site Neutrality and 340B Programs—Implications for Oncology Services: https://www.blankrome.com/publications/impact-recent-cms-rule-site-neutrality-and-340b-programs-implications-oncologyCITI Program's course catalog: https://about.citiprogram.org/course-catalog  

In this Special Episode of the ASC Podcast with John Goehle recorded live from the Ohio Association of Ambulatory Surgery Centers Annual Conference in Columbus Ohio we interview some of the speakers and discuss recent activities for the association and the benefits of membership in the Association.   This episode is sponsored by Surgical Information Systems, RFX Solutions, Medserve and  Ambulatory Healthcare Strategies.   Notes and Resources from this Episode: Membership Information for the Ohio Association: http://www.oaasc.net/aws/OAASC/pt/sp/join ASCA Membership Information: https://www.ascassociation.org/asca/membership/join-renew Dinsmore https://www.dinsmore.com/ INFORMATION ABOUT THE ASC PODCAST WITH JOHN GOEHLE ASC Central, a sister site to http://ascpodcast.com provides a link to all of our bootcamps, educational programs and membership programs! https://conferences.asc-central.com/ Join one of our Membership Programs! Our Patron Program: Patron Members of the ASC Podcast with John Goehle have access to ASC Central - an exclusive membership website that provides a one-stop  ASC Regulatory and Accreditation Compliance, Operations and Financial Management resource for busy Administrators, nurse managers and business office managers.  More information and Become Member The ASC-Central Premium Access Program A Premium Resource for Ambulatory Surgery Centers including access to bootcamps, education programs and private sessions More Information and Become a Premium Access Program Members Today! Important Resources for ASCs: Conditions for Coverage: https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&rgn=div5&view=text&node=42:3.0.1.1.3&idno=42#se42.3.416_150 Infection Control Survey Tool (Used by Surveyors for Infection Control) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107_exhibit_351.pdf Updated Guidance for Ambulatory Surgical Centers - Appendix L of the State Operations Manual (SOM) https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_l_ambulatory.pdf https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/updated-guidance-ambulatory-surgical-centers-appendix-l-state-operations-manual-som Policy & Memos to States and Regions CMS Quality Safety & Oversight memoranda, guidance, clarifications and instructions to State Survey Agencies and CMS Regional Offices. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions Other Resources from the ASC Podcast with John Goehle: Visit the ASC Podcast with John Goehle Website Books by John Goehle Get a copy of John's most popular book - The Survey Guide - A Guide to the CMS Conditions for Coverage & Interpretive Guidelines for Ambulatory Surgery Centers

Please join HRS Digital Education Committee Vice-Chair, Tina Baykaner, MD, MPH, of Stanford University, as she is joined by Heart Rhythm Society President Mina K. Chung, MD, FHRS, of the Cleveland Clinic, and Konstantinos C. Siontis, MD, FHRS of the May Clinic. The three met up in Altanta at HRX 2025 for this stimulating coversation. This study evaluated whether artificial intelligence applied to single-lead ambulatory ECGs could predict imminent sustained ventricular arrhythmias. Using deep learning models, the researchers demonstrated that AI could identify subtle ECG features preceding arrhythmic events, enabling accurate short-term risk prediction. The findings suggest a potential role for AI-enhanced ECG monitoring to improve early detection and prevention of life-threatening ventricular arrhythmias. To view bonus video recorded LIVE at HRX 2025 in Atlanta, view this episode on Heart Rhythm 365 or the HRX Innovation Hub! Article Authors Laurent Fiorina ∙ Tanner Carbonati∙ Kumar Narayanan ∙ Jia Li ∙ Christine Henry ∙ Jagmeet Singh ∙ Eloi Marijon Read the Article: https://www.heartrhythmjournal.com/article/S1547-5271(23)02195-1/fulltext Podcast Contributors and Disclosures Tina Baykaner, MD, MPH | Stanford University Mina K. Chung, MD, FHRS | Cleveland Clinic Konstantinos C. Siontis, MD, FHRS | Mayo Clinic All relevant financial relationships have been mitigated. T. Baykaner:   •Honoraria/Speaking/Consulting: Volta Medical, Medtronic, Pacemate, Johnson and Johnson, Abbot Medical, Boston Scientific Research: NIH M. Chung: •Honoraria/Speaking/Consulting: University of Chicago, Cedars Sinai Medical Center, Asia Pacific Heart Rhythm Society, NIH, Baylor College of Medicine, Kansas City Heart Rhythm Symposium, American College of Cardiology, Geisinger Health Systems, ABIM, Academy for Continued Healthcare Learning, MediasphereMedical, Western AF Symposium, University of Minnesota, Stanford University, Canadian Heart Rhythm Society •Research: NIH, American Heart Association •Royalty Income: Elsevier, Wolters Kluver •Officer: American Heart Association K. Siontis: •Research: Anumana, Varian Medical Systems •Intellectual Property Right: Anumana •Speaking/Teaching/Consulting: EBAMedSA, AskBio

This episode recorded live at the Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Janet L. Carlson, Vice President of Ambulatory Operations, Commonwealth Pain & Spine. Janet shares insights on emerging trends in outpatient spine and orthopedic care, from smart implants and digital patient engagement to financial transparency and strategies for retaining top clinical talent.

What do interoperability and plumbing have in common? NextGen Healthcare's Muhammad (Mo) Chebli, vice president of product management for interoperability, and Curtis Bailey, senior solutions engineer, answer this question in a thought-provoking new episode. They also highlight the relationship between interoperability and AI and discuss features of the latest release of Mirth Connect by NextGen Healthcare, including the new Mirth Command Center. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, Tammy Smittle, CEO of Stonegate Surgery Center, discusses the shift of higher acuity procedures to ASCs, direct partnerships with employers, and rising hospital investment in outpatient settings. She also highlights upcoming regulatory changes and her balanced approach to growth through physician recruitment, innovation, and strong internal relationships.

In this episode, Michael Gale, Administrative Director at Sentara Obici Ambulatory Surgical Center shares insights on the migration of higher acuity cases to ASCs, obstacles posed by certificate of need laws, and the importance of tailored patient care in today's evolving ambulatory landscape.

In this episode, Tracy D. Chu, Corporate VP of Population Health and Chief Executive of the ACO at Scripps Health, shares how integrated leadership across operations and strategy enables better execution in ambulatory care and value-based models. She discusses managing capacity, recognizing early warning signs in teams, and the importance of intentional leadership in supporting high-performing healthcare organizations.

Biosecurity plans aren't just for hospitals and events—here's why every ambulatory equine veterinarian needs one too. https://equimanagement.com/research-medical/disease/building-a-mobile-defense-biosecurity-plans-for-ambulatory-equine-veterinarians/Mentioned in this episode:Purina Microbiome Quotientmq.purinamills.comEquiManagement on Audio All the articles you have come to love in EquiManagement Magazine are now available in this podcast for free. Each article is released as its own separate episode to make them quick and easy to listen to. EquiManagement always has the latest insights on equine health, veterinary practice management, and veterinarian wellness.

The white-coat effect is a measure of blood pressure change from before to during the visit in office/clinic when the blood pressure is recorded by a physician or nurse; this was first described in 1983 by Mancia et al, and was initially thought to represent a benign process. But it was unclear what this actually meant for pregnancy. Ambulatory blood pressure monitoring (ABPM) has been used in pregnancy for about 20 years now. Use of this monitoring option has revealed a subgroup of patients who have persistently high blood pressure (BP) in the presence of health care providers, but a normal ambulatory or self-measured BP. This phenomenon has been termed “White Coat Hypertension” (WCH). In 2013, The International Society for the Study of Hypertension in Pregnancy (ISSHP) published the revised classification for hypertensive disorders in pregnancy, that included WCH, not previously included. The ISSHP guidelines also emphasize that a diagnosis of white coat hypertension in pregnancy should only be considered before 20 weeks of gestation. We now know that WCH, outside of pregnancy, is not an entirely benign process. The role of metabolic risk factors in patients with white-coat hypertension was first outlined in 2000 by Kario and Pickering. When metabolic risk factors are present in association with white-coat hypertension, the increased risk of target organ damage is determined not only by the blood pressure characteristics but also by the metabolic abnormalities. Recognizing the potential risks of white coat hypertension was also published in a commentary in 2016 out of the European Society of Cardiology. That article's title was, “White-coat hypertension: not so innocent”. But what is the latest data on WCH in pregnancy? Is WCH linked to poor obstetrical outcomes? Does WHC need medication therapy? We have data from 2024 to help us. Listen in for details.

In this 308th episode I welcome Dr. Tim Kajstura back to the show for another ABA Keyword episode. We cover Ambulatory Anesthesia. Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/accrac50offAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy